Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

Blog

  • Home
  •  
  • Blog



  • Most Read
  • Latest Comments
  • Blog
    • News

    RBA and ASIC up the ante on blockchain project, ASX writes off millions
    Public
  • Blog
    • Satire

    Australia to close borders to Omicron Persei 8
    Public
  • Blog
    • Opinion

    The New Criterion: will the listed sanitiser stocks clean up – or clean out – investors?
    Public
  • Blog
    • Opinion

    Is this the most hated company on the ASX?
    Public
  • Blog
    Opening a new frontier in treating Parkinson’s disease
    • Review
    • November 11, 2022
  • Tremors from the FTX collapse continue to be felt as DigitalX sells off 15% Bitcoin holdings
    • Review
    • January 10, 2023
  • AUDC stablecoin gathers momentum as Novatti confirms integration with XRP Ledger
    • Review
    • June 9, 2022
  • PharmAust completes dosing first cohort for MND treatment, patients respond positively
    • Review
    • January 6, 2023
  • Is this the most hated company on the ASX?
    • Review
    • August 16, 2019

Latest Articles

  • AML3D announces stronger FY26, with positive EBITDA reported in the second half
    AML3D announces stronger FY26, with positive EBITDA reported in the second half
    • News

  • Refurbished tech gives Harris Technology a second life
    Refurbished tech gives Harris Technology a second life
    • News

  • Imagion Biosystems Advances MagSense® Phase 2 Trial
    Imagion Biosystems Advances MagSense® Phase 2 Trial
    • News

  • Acrux-developed Menopause Hormone Therapy to enter Australian market
    Acrux-developed Menopause Hormone Therapy to enter Australian market
    • News

  • Evion Expands Critical Minerals Push with Nevada Fluorspar Option
    Evion Expands Critical Minerals Push with Nevada Fluorspar Option
    • News

  • Universal Biosensors secures five more distributors for its Petrackr diabetes monitor
    • News

    Universal Biosensors secures five more distributors for its Petrackr diabetes monitor

    Bolstering its market presence and catering for growing demand from pet health conscious owners, Universal Biosensors (ASX: UBI) has secured partnerships with five new distribution partners for its Petrackr product. Petrackr is a biosensor tech product developed by Universal Biosensors, designed to monitor and track the level of blood glucose in real-time. These biomarkers hold

    Read More
    Public
  • Vection to acquire 3D fashion tech company MYR to enhance fashion tech suite
    • News

    Vection to acquire 3D fashion tech company MYR to enhance fashion tech suite

    As software company Vection Technologies (ASX: VR1) strives to rule the roost on the digital fashion runway, it is enhancing its IntegratedXR suite of products through acquisitions. The most recent one is the acquisition of 3D fashion tech company, MYR Look Customiser. This follows the acquisition of Invrsion, another 3D tech company working in fashion,

    Read More
    Public
  • Incannex set to start psychedelic-assisted PTSD treatment in September after TGA approval
    • News

    Incannex set to start psychedelic-assisted PTSD treatment in September after TGA approval

    Health experts in Australia believe that around 12% of Australians will experience PTSD (post-traumatic stress disorder) at some point in their lives, and about 1.5% of the population, i.e. almost 390,000 people, currently have a PTSD diagnosis. Certain groups, like those in the defence force, military veterans, first responders, and some minority communities, are more

    Read More
    Public
  • US markets rebound after four session of selling, XJO expected to open higher
    • Market Update

    US markets rebound after four session of selling, XJO expected to open higher

    The XJO is expected to open higher this morning following a rally in the U.S overnight. Their futures sit flat this morning. Yesterday was a fairly mild day where we once again indicated that we are willing to hold the key support at roughly 7,280 as we bounced intraday to finish marginally in the red.

    Read More
    Public
  • Organic growth surging as Healthia rollout of allied health initiatives catch up the pandemic delays
    • News

    Organic growth surging as Healthia rollout of allied health initiatives catch up the pandemic delays

    While pandemic travel restrictions were more commonly linked to tourism businesses, the resumption of movement in FY23 enabled allied health company Healthia (ASX: HLA) to resume moving its teams around Australia and New Zealand to rollout a range of organic growth initiatives that are now bearing fruit.  Operating more than 300 allied health clinics across

    Read More
    Public
  • Amid declining population, Memphasys and Vitrolife team up to provide IVF treatments to boost numbers
    • News

    Amid declining population, Memphasys and Vitrolife team up to provide IVF treatments to boost numbers

    For over seven years, Japan’s birth rate has been witnessing a decline. Its fertility rate has fallen below the rate required to maintain a population. Of course, the consequences are dire, ranging from a small labour force to vulnerable borders. The Japanese government has been investing in developing childcare packages to entice people into having

    Read More
    Public
  • «
  • ‹
  • 203
  • 204
  • 205
  • 206
  • 207
  • ›
  • »

Login or register for free to access unlimited reading

Register Now!
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.